ArticleJournal of neuro-oncology2024

Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.

Ting Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.